logo

Press Journals

Surgical Site Infection (SSI) Market to Reach $5.9 Billion by 2023

June 2018

Global surgical site infection market is forecasted to reach $5.9 billion by 2023, according to P&S Market Research.

The market growth can be attributed to the development of technologically advanced products and growing geriatric population. Furthermore, increasing number of surgical procedures and rising incidence of SSIs are boosting the market growth.

Insights on market segments

Antibiotic prophylaxis products generated the largest revenue in the surgical site infection market in 2017. In most cases, patients’ sensitivity to certain drugs creates the need for specific antibiotics, which, in turn, adds to the treatment cost. Owing to this factor, antibiotic prophylaxis products continue to be in high demand in the market. However, the fastest growth in the market during the forecast period is expected from the antiseptic and disinfectant product category, with a CAGR of 7.4%.


Among all phases, the demand for products for the intraoperative phase is expected to exhibit the fastest growth in the surgical site infection market, at a CAGR of 6.6%, during the forecast period. This can be attributed to the wide usage of SSI preventive products during the intraoperative phase, as the chances of contamination to open wounds are the highest during this phase. Also, due to this reason, healthcare facilities are increasingly complying with the World Health Organization (WHO) guidelines that suggest measures to prevent infections.

Browse report overview with 113 tables and 68 figures spread through 177 pages and detailed TOC on "Surgical Site Infection (SSI) Market by Product (Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Wound Care Dressings, Surgical Drapes, Surgical Staff Clothing, Patient-Warming Products, Wound Care Supplementary Products, Clippers, Wound Irrigation Products), by Phase (Intraoperative Phase, Preoperative Phase, Postoperative Phase), by End User (Hospitals, Ambulatory Surgical Centers [ASCs], Clinics), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at:https://www.psmarketresearch.com/market-analysis/surgical-site-infection-market

Hospitals have been contributing the largest revenue to the surgical site infection market, owing to increase in the number of surgeries and a significant increase in the number of hospitals on a global level, which is further leading to the increased use of products that help prevent surgical site infections.

Market is projected to witness the fastest growth in Asia-Pacific (APAC)

During the forecast period, the surgical site infection market is expected to witness the fastest growth in APAC, at a CAGR of 7.7%. The APAC surgical site infection market is also expected to reach $1,492.8 million by 2023. The market growth in APAC is mainly driven by growing geriatric population, rising incidence of SSIs, increasing adoption of technologically advanced products, and improving healthcare infrastructure.

According to the UN publication World Population Ageing 2017, in Asia, the number of people aged 60 years or above is estimated to increase from 549 million in 2017 to nearly 1.3 billion in 2050. Also, there is a high adoption rate of technologically advanced products in Japan. Besides, the country is witnessing an increase in its geriatric population. These factors are expected to continue driving the growth of the surgical site infection market market in Japan.

According to Japan Nosocomial Infections Surveillance (JANIS), a national surveillance program organized by Japan’s Ministry of Health, Labour and Welfare (MHLW) in 2017, there were 117,209 cases of methicillin-resistant Staphylococcus aureus (MRSA) infection in 2012, which increased to 177,768 in 2016. Thus, increase in surgical site infections in Japan is boosting the demand for products that help fight these infections.

Key players are seeking partnerships to increase their market share

In order to increase their market share, key players of the surgical site infection industry are entering into partnerships. For instance, in January 2018, Mölnlycke Health Care AB entered into a partnership with Tissue Analytics, a developer of digital wound-imaging platforms. With this partnership, both the companies intend to jointly develop and commercialize innovative digital solutions (such as comprehensive clinical decision support tools) for wound care professionals.

Some of the other key players operating in the surgical site infection market are 3M Company, STERIS plc, Stryker Corporation, Medtronic plc, Prescient Surgical Inc., Covalon Technologies Ltd., Surgical Site Infection Prevention LLC, HARTMANN GROUP, B. Braun Melsungen AG, and Becton, Dickinson and Company.

GLOBAL SURGICAL SITE INFECTION (SSI) MARKET SEGMENTATION

Market Segmentation by Product

  • Antibiotic Prophylaxis Products
  • Antiseptics and Disinfectants
  • Wound Care Dressings
  • Surgical Drapes
  • Surgical Staff Clothing
  • Patient-Warming Products
  • Wound Care Supplementary Products
  • Clippers
  • Wound Irrigation Products
  • Others

Market Segmentation by Phase

  • Intraoperative Phase
    • Surgical Drapes
    • Surgical Staff Clothing
    • Wound Care Dressings
    • Patient-Warming Products
    • Antiseptics and Disinfectants
    • Wound Care Supplementary Products
    • Others
  • Preoperative Phase
    • Antibiotic Prophylaxis Products
    • Antiseptics and Disinfectants
    • Clippers
    • Others
  • Postoperative Phase
    • Wound Care Dressings
    • Wound Care Supplementary Products
    • Wound Irrigation Products
    • Others

Market Segmentation by End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Clinics
  • Others

Market Segmentation by Geography

  • North America Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country – U.S. and Canada
  • Europe Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country – Germany, U.K., France, Italy, Spain, and Rest of Europe
  • Asia-Pacific (APAC) Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country – Japan, China, India, Australia, South Korea, and Rest of APAC
  • Rest of the World (RoW) Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country – Brazil, Mexico, Saudi Arabia, South Africa, and Rest of RoW

SSI Incidence and Forecast by Country

  • U.S. SSI Incidence and Forecast
    • By Surgery Type
  • Canada SSI Incidence and Forecast
    • By Surgery Type
  • Germany SSI Incidence and Forecast
    • By Surgery Type
  • U.K. SSI Incidence and Forecast
    • By Surgery Type
  • France SSI Incidence and Forecast
    • By Surgery Type
  • Italy SSI Incidence and Forecast
    • By Surgery Type
  • Spain SSI Incidence and Forecast
    • By Surgery Type
  • Japan SSI Incidence and Forecast
    • By Surgery Type
  • China SSI Incidence and Forecast
    • By Surgery Type
  • India SSI Incidence and Forecast
    • By Surgery Type
  • Australia SSI Incidence and Forecast
    • By Surgery Type
  • South Korea SSI Incidence and Forecast
    • By Surgery Type
  • Brazil SSI Incidence and Forecast
    • By Surgery Type
  • Mexico SSI Incidence and Forecast
    • By Surgery Type
  • Saudi Arabia SSI Incidence and Forecast
    • By Surgery Type
  • South Africa SSI Incidence and Forecast
    • By Surgery Type